RNA
Atrium Therapeutics, Inc.
8.40$
+1.6%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +91.0% | +100.5% | -96.8% | +2,333.6% | +244.6% | +28.1% | +49.4% | -1.6% | +148.8% | -82.2% | |
| – | – | – | – | +2,851.1% | +246.7% | +24.0% | +51.5% | -1.9% | +152.3% | -82.3% | |
| – | +120.9% | +110.9% | -97.3% | +2,960.8% | +247.0% | -2.3% | +6.2% | -45.6% | +18.8% | +22.8% | |
| – | – | – | – | +2,960.8% | +247.0% | +23.6% | +50.6% | -2.5% | +152.2% | -82.0% | |
| – | – | – | – | – | +50.0% | -25.0% | +330.6% | +122.5% | +227.3% | -55.9% | |
| – | – | – | – | – | -120,000,100.0% | – | – | -733,300,100.0% | – | – | |
| – | -21.1% | -6.0% | -76.6% | -10.1% | +204.6% | +711.1% | -3.7% | – | – | – | |
| – | -2.3% | -8.9% | – | – | – | – | – | – | – | – | |
| – | +43.1% | -9.2% | +18.7% | +259.7% | -82.9% | +66.8% | +31.6% | +110.4% | +8.7% | -48.8% | |
| – | +4.0% | -22.2% | -63.1% | +121.8% | +42.5% | +103.3% | +75.0% | +55.4% | +21.5% | -57.4% | |
| – | – | – | – | +1.0% | +179.2% | -77.2% | +75.5% | +17.2% | +5.6% | -4.5% | |
| – | -3.9% | -16.5% | -40.5% | +47.5% | +235.6% | -63.8% | +65.3% | +90.0% | -4.0% | -48.0% | |
| – | +152.4% | +28.6% | -27.9% | -76.6% | – | – | – | – | – | – | |
| – | +501.9% | +324.1% | -147.2% | – | – | +24.6% | +51.6% | -13.4% | +184.6% | -85.5% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +81.4% | -42.2% | +91.2% | +25.9% | +40.0% | +52.8% | -84.7% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.